E. coli N (%) | K. pneumonia N (%) | KESC # N (%) | Other## N (%) | Total N isolates N (%) | Mortality N (%) | |
---|---|---|---|---|---|---|
CREpos screening (%) | 185 (41)P 185 (35)I | 173 (38)P 173 (32)I | 116 (26)P 116 (22)I | 62 (14)P 62 (12)I | 453 (118) P* 536 (100) I * | 167/694(24) |
HAI isolates (%) | 21/59 (36) | 37/59 (63) | 1/59(2) | 0 (0) | 59/59 (100) | 26/59 (44) |
Blood (%) | 7/21 (33) | 15/37(41) | 7/17 (41) | 0 (0) | 22/59 (37) | 10/22 (45) |
Tracheal aspirate (%) | 14/21 (66) | 22/37 (59) | 10/17 (59) | 3/3 (100) | 37/59 (63) | 16/37 (43) |
Carbapenem R/S (%R) | 6/4(60) | 15/3(83) | 7/0 (100) | 2/2 (100) | 22/7 (76) | R12/22(55); S3/7(43) |
Gentamycin R/S (%R) | 6/4 (60) | 13/5 (72) | 7/0 (100) | 2/2 (100) | 20/9 (69) | R11/20(55); S4/9(44) |
Mortality CREpos (%) | 36/185 (19) | 34/173 (20) | 20/116 (17) | 10/62 (16) | 71/453 (16) | 71/694 (10) |
Mortality HAI (%) | 8/21 (38) | 17/37(46) | 8/17 (47) | 3/3 (100) | 26/59 (44) | 26/694 (4) |